A multicenter, randomized, open-labeled study to steer immunosuppressive and antiviral therapy by measurement of virus (CMV, ADV, HSV)-specific T cells in addition to determination of trough levels of immunosuppressants in pediatric kidney allograft recipients (IVIST01-trial): study protocol for a randomized controlled trial

Title
A multicenter, randomized, open-labeled study to steer immunosuppressive and antiviral therapy by measurement of virus (CMV, ADV, HSV)-specific T cells in addition to determination of trough levels of immunosuppressants in pediatric kidney allograft recipients (IVIST01-trial): study protocol for a randomized controlled trial
Authors
Keywords
Kidney transplantation, Immunosuppression, Virus-specific T cells, Personalized immunosuppressive therapy, Viral infections, Pediatric transplantation, Cytomegalovirus, Antiviral therapy, Over-immunosuppression, Immunomonitoring, Drug-monitoring
Journal
Trials
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-08-16
DOI
10.1186/1745-6215-15-324

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started